Filing Details
- Accession Number:
- 0001209191-22-035010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-08 16:06:06
- Reporting Period:
- 2022-06-07
- Accepted Time:
- 2022-06-08 16:06:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1700225 | J. Vincent Angotti | C/O Acelrx Pharmaceuticals, Inc. 25821 Industrial Blvd., Suite 400 Hayward CA 94545 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-07 | 46,400 | $0.22 | 1,016,919 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.2187 to $0.2241 on June 7, 2022. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.